arXiv (All)
open access
PK/PD-integrated Bayesian platform design for phase II dose regimen optimization
Early-phase dose-finding methods increasingly assess toxicity and efficacy jointly, but comparisons based only on administered dose may inadequately characterize regimens differing in schedule. We developed a Bayesian phase II adaptive platform design for regimen optimization that integrates pharmac
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Optimal Biological Dose Combination Finding: A Design Roadmap and Robust Cross-Indication Bayesian Borrowing#1049532
- A staggered seamless dose-optimization design for co-developing monotherapy and combination therapy#822368
- Dose Optimization of MDMA-Assisted Therapy for PTSD#835874
- Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC#863235
- PNU 166148 in Treating Patients With Metastatic Solid Tumors#840568
Record · ID 1078143
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive